Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
June 27, 2023
0Patent Application Number
178586640
Date Filed
July 6, 2022
0Patent Citations
Patent Primary Examiner
The disclosure relates to compositions and methods for the preparation, manufacture and therapeutic use of polynucleotide molecules comprising an mRNA encoding an OX40L polypeptide. Also provided is a method for activating T cells or increasing the number of NK cells in a subject in need thereof.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
